Activity of antibodies recovered from immune complexes of ovarian cancer patients
- PMID: 6383602
- PMCID: PMC11039213
- DOI: 10.1007/BF00205483
Activity of antibodies recovered from immune complexes of ovarian cancer patients
Abstract
Ascites fluids from ovarian cancer patients contain immune complexes (IC). Attempts were made to characterize those antigens to which the patient is reacting using antibody recovered from these complexes. Polyethylene glycol (PEG) precipitation and protein A Sepharose 4B affinity chromatography were used to isolate IC. Dissociation of the IC was achieved by G-150 gel filtration in 0.1 M acetic acid, 0.15 M NaCl. Activity of antibody preparations was measured using a binding assay with 125I-labeled staphylococcal protein A. Confluent monolayers of various cell lines (including human ovarian and cervical carcinoma lines, human lymphoblastoid cell lines, human and chick embryo fibroblasts) were used. Six of nine antibody preparations isolated from ovarian cancer patient IC contained at least some reactivity against all cell types. Specificity was further defined using cell adsorption assays and polyacrylamide gel electrophoresis. These results indicate what appears to be autoreactivity directed against a normal component(s) of many cells. No evidence for an ovarian cancer-restricted response was shown. Immunoprecipitation analyses showed several polypeptide bands on autoradiograms (49K, 46K, 33K, 25K), which deviated distinctly from the pattern obtained for whole cell extracts.
Similar articles
-
The study of antibodies and antigens dissociated from the immune complexes extracted from ovarian carcinoma ascitic fluid.Gynecol Oncol. 1985 Jan;20(1):100-8. doi: 10.1016/0090-8258(85)90130-1. Gynecol Oncol. 1985. PMID: 3965372
-
Detection of human ovarian tumor-associated antigens by antibodies isolated from ovarian carcinoma ascitic fluid.Am J Obstet Gynecol. 1988 Jul;159(1):94-8. doi: 10.1016/0002-9378(88)90500-5. Am J Obstet Gynecol. 1988. PMID: 3394756
-
Ovarian cancer-associated antibodies recovered from ascites: their use for the isolation of ovarian cancer-associated antigen to produce monoclonal antibodies.Gynecol Oncol. 1990 Apr;37(1):24-8. doi: 10.1016/0090-8258(90)90301-z. Gynecol Oncol. 1990. PMID: 2182406
-
Detection of human ovarian tumor-associated antigens by sandwich enzyme immunoassay.Obstet Gynecol. 1988 Mar;71(3 Pt 1):423-8. Obstet Gynecol. 1988. PMID: 3279355
-
Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.Obstet Gynecol Surv. 1984 Jun;39(6):346-60. Obstet Gynecol Surv. 1984. PMID: 6203071 Review.
Cited by
-
Isolation and dissociation of immune complexes from pleural effusions of lymphoma patients.Cancer Immunol Immunother. 1986;23(1):51-5. doi: 10.1007/BF00205555. Cancer Immunol Immunother. 1986. PMID: 3533257 Free PMC article.
References
-
- Barber HRK. Ovarian cancer. Part 1. CA. 1979;29:342.
-
- Bhattacharya N, Barlow JJ. Ovarian cystadenocarcinoma associated antigen (OCAA) In: Herberman RB, editor. Compendium of assays for immunodiagnosis of human cancer. New York: Elsevier/North-Holland; 1979. p. 527.
-
- Bhattacharya M, Chatterjee SK, Barlow JJ. Uridine 5′-diphosphate-galactose: glycoprotein galactosyltransferase activity in the ovarian cancer patient. Cancer Res. 1976;36:2096. - PubMed
-
- Brown JP, Klitzman JM, Hellstrom KE. A microassay for antibody binding to tumor cell surface antigens using 125I-labeled protein A from Staphylococcus aureus. J Immunol Methods. 1977;15:57. - PubMed
-
- Clayton LA, Gall SA, Dawson JR, Creasman WT. Immune complexes in ovarian cancer. Gynecol Oncol. 1982;13:203. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical